Mass spectroscopy chromatogram: (a) patient plasma with enzalutamide peak with extracted ion chromatogram adduct (465?m/z); (b) in the same patient, plasma sample with undetectable digoxin peak, and undetectable digoxin ammoniated adduct at 798?m/z; and (c) plasma control sample spiked with digoxin (30??g/L) with detected digoxin peak and extracted ion chromatogram digoxin ammoniated adduct (798?m/z). Credit: Medical Journal of Australia (2024). DOI: 10.5694/mja2.52289 Teams at two of Melbourne’s leading research and medical institutes are developing high-tech solutions to rapidly test for drugs and better treat patients presenting to hospital. The researchers Read More